[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2009167209A - トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物 - Google Patents

トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物 Download PDF

Info

Publication number
JP2009167209A
JP2009167209A JP2009101792A JP2009101792A JP2009167209A JP 2009167209 A JP2009167209 A JP 2009167209A JP 2009101792 A JP2009101792 A JP 2009101792A JP 2009101792 A JP2009101792 A JP 2009101792A JP 2009167209 A JP2009167209 A JP 2009167209A
Authority
JP
Japan
Prior art keywords
group
collagen
formula
compound
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009101792A
Other languages
English (en)
Japanese (ja)
Inventor
Seishi Azuma
清史 東
Akiko Kakimizu
明子 垣水
Chizuko Takahashi
千鶴子 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP2009101792A priority Critical patent/JP2009167209A/ja
Publication of JP2009167209A publication Critical patent/JP2009167209A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2009101792A 2003-10-03 2009-04-20 トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物 Pending JP2009167209A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009101792A JP2009167209A (ja) 2003-10-03 2009-04-20 トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003345472 2003-10-03
JP2009101792A JP2009167209A (ja) 2003-10-03 2009-04-20 トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004286810A Division JP4353046B2 (ja) 2003-10-03 2004-09-30 トリアジノインドールアミン化合物

Publications (1)

Publication Number Publication Date
JP2009167209A true JP2009167209A (ja) 2009-07-30

Family

ID=34419457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009101792A Pending JP2009167209A (ja) 2003-10-03 2009-04-20 トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物

Country Status (2)

Country Link
JP (1) JP2009167209A (fr)
WO (1) WO2005033109A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116152D0 (en) * 2011-09-19 2011-11-02 Isis Innovation Cannabinoid-2-receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023720A (en) * 1963-09-17 1966-03-23 Allen & Hanburys Ltd as-triazino (5,6-b)indoles
JPS62132882A (ja) * 1985-12-04 1987-06-16 Sumitomo Chem Co Ltd トリアジノインド−ル誘導体、その製造法およびそれを有効成分とする除草剤
FR2772612B1 (fr) * 1997-12-19 2003-01-10 Oreal Utilisation de l'acide cinnamique ou de ses derives dans une composition cosmetique raffermissante

Also Published As

Publication number Publication date
WO2005033109A1 (fr) 2005-04-14

Similar Documents

Publication Publication Date Title
HU229308B1 (en) Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
JP2017529071A (ja) カンナビノイド化合物を同時作製する装置及び方法
PT1525177E (pt) Derivados substituídos de 1, 3-difenilprop-2-en-1-ona e a sua preparação e utilização.
CN104936591A (zh) 促红细胞生成素表达增强剂
HU230061B1 (hu) Cikloalkénszármazékok, előállításuk és alkalmazásuk
WO2007132948A1 (fr) Composé de cinnamoyle et leur utilisation
WO2007136125A1 (fr) Composé ayant un noyau hétérocyclique et son utilisation
WO2004071509A1 (fr) Promoteurs de differenciation d'oligodendrocyte
WO2006093339A1 (fr) Emploi d'un composé de type cinnamoyle
JPWO2003086334A1 (ja) 育毛剤
EP1671950B1 (fr) Derives de cinnamoyle et utilisation de ceux-ci
CA2935319A1 (fr) Derive de 1,2-naphtoquinone et son procede de preparation
WO2006100922A1 (fr) Dérivé de cinnamoyle et ses applications
JP2015518484A (ja) ゲラニルゲラニルアセトン類似化合物及びその使用
JP4353046B2 (ja) トリアジノインドールアミン化合物
WO2007145253A1 (fr) INHIBITEUR DE L'ACTIVATION DU NF-ϰB
JP2009167209A (ja) トリアジノインドールアミン化合物又はその薬学的に許容される塩を有効成分として含有するコラーゲン蓄積促進及び/又は減少抑制のための組成物
WO2003080592A1 (fr) Composés 2-pyrone et utilisation de ceux-ci
JP2004123621A (ja) 4−メトキシ−1−ベンゾピラン−2−オン化合物及びその利用
JP2015010075A (ja) γ−グルタミルシクロトランスフェラーゼ阻害剤
KR100574684B1 (ko) 암세포 성장 억제기능 및 세포주기 조절 기능을 가지는신규 시남알데하이드 유도체, 이의 제조방법 및 이를유효성분으로 함유하는 약학적 조성물
JP2004123620A (ja) 4−ヒドロキシ−1−ベンゾピラン−2−オン化合物及びその利用
JP2004175780A (ja) 2−ピロン化合物およびその用途
KR102383733B1 (ko) 세스퀴테르펜 유도체를 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학적 조성물
JPH06135968A (ja) ヒダントイン誘導体及びその塩並びにこれらを有効成分とするメイラード反応阻害剤

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120508

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120918